Fill out this form and we’ll get back to you shortly.
Need help or account access? View our support resources or sign in.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 9, 2024 - Armas launched an AB-rated generic version of Bausch and Lomb’s Alrex (loteprednol) 0.2% ophthalmic suspension.
Download PDF
Return to publications
